109 related articles for article (PubMed ID: 66210)
21. Macrophage electrophoretic mobility test as sensitive probe of transplantation immunity in mice.
Malkovský M; Bubeńik J; Boubelík M; Hausner P
Transplantation; 1979 Aug; 28(2):121-4. PubMed ID: 384619
[TBL] [Abstract][Full Text] [Related]
22. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)].
Bauer HW; Richter H; Schottler S; Ax W
Chir Forum Exp Klin Forsch; 1978; (1978):215-9. PubMed ID: 752589
[TBL] [Abstract][Full Text] [Related]
24. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
25. A reappraisal of the macrophage electrophoretic mobility (MEM) test for the measurement of lymphokine activity.
Brown KA; Wolstencroft RA; Booth CG; Dumonde DC
J Immunol Methods; 1985 Oct; 82(2):189-98. PubMed ID: 3900214
[TBL] [Abstract][Full Text] [Related]
26. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
Shenton BK; Hughes D; Field EJ
Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
[TBL] [Abstract][Full Text] [Related]
27. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
[TBL] [Abstract][Full Text] [Related]
28. Is macrophage migration inhibition a useful test of colorectal cancer?
Isbister WH; McLeod DM
Aust N Z J Surg; 1986 Jan; 56(1):43-5. PubMed ID: 3461769
[No Abstract] [Full Text] [Related]
29. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Cerni CH; Micksche M
Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
[TBL] [Abstract][Full Text] [Related]
30. A human lymphokine released by mononuclear blood cells upon contact with CEA.
Müller M; Grossmann H; Wagner H; Irmscher J; Kotzsch M
Immunol Lett; 1986 Mar; 12(2-3):159-64. PubMed ID: 3721537
[TBL] [Abstract][Full Text] [Related]
31. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test.
Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK
Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680
[TBL] [Abstract][Full Text] [Related]
32. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
Muhrer KH; Kahle M; Pasurka B
Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
[TBL] [Abstract][Full Text] [Related]
33. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
34. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
Kowalczyk D; Zembala M; Popiela T; Labza H
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793
[TBL] [Abstract][Full Text] [Related]
35. Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.
Shi YD; Tang ZS; Lian ZJ; Lu CZ; Xiao BG
Br J Cancer; 1981 Apr; 43(4):532-6. PubMed ID: 6165370
[No Abstract] [Full Text] [Related]
36. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
37. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
38. Preliminary characterization of a colon tumour tissue preparation used in macrophage electrophoretic mobility (MEM) test1.
Grossmann H; Müller M; Heidl G; Irmscher J; Kotzsch M; Wagner H
Arch Geschwulstforsch; 1981; 51(4):310-6. PubMed ID: 7032449
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum.
Guillou PJ; Giles GR
Gut; 1973 Sep; 14(9):733-8. PubMed ID: 4201667
[TBL] [Abstract][Full Text] [Related]
40. Disturbance of cell-mediated immunity in patients with carcinoma of colon and rectum.
Manousos ON; Economidou J; Pathouli C; Merikas G
Gut; 1973 Sep; 14(9):739-42. PubMed ID: 4752038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
